Сампрост
Producer: LLC Samson-Med Russia
Code of automatic telephone exchange: G04BX
Pharm group: a href="javascript:if(confirm(%27medicalmeds.eu/preparats_title.php?name=-1&mnn=-1&atc=108 \n\nThis file was not retrieved by Teleport Pro, because it is linked too far away from its Starting Address. If you increase the in-domain depth setting for the Starting Address, this file will be queued for retrieval. \n\nDo you want to open it from the server?%27))window.location=%27medicalmeds.eu/preparats_title.php?name=-1&mnn=-1&atc=108%27" tppabs="medicalmeds.eu/preparats_title.php?name=-1&mnn=-1&atc=108">Drugs for treatment of urological diseases
Release form: Liquid dosage forms. Lyophilisate for preparation of solution for injections.
General characteristics. Structure:
Active ingredient: 5 mg of extract of tissue of prostate of the bull-calves who reached puberty.
Excipient: glycine.
The complex of biologically active peptides of a prostate received by way of extraction from tissue of a prostate of the bull-calves who reached puberty, promoting reduction of hypostasis, leukocytic infiltration and thrombosis of venules of a prostate; normalizing secretory function of epithelial cells, increasing amount of lecithin grains in a secret of an acinus; the stimulating muscle tone of a bladder; reducing a thrombogenesis and having antiagregantny activity.
Pharmacological properties:
Pharmacodynamics. Promotes reduction of hypostasis, leukocytic infiltration and thrombosis of venules of a prostate, normalizes secretory function of epithelial cells, increases amount of lecithin grains in a secret of an acinus, stimulates a muscle tone of a bladder. Reduces a thrombogenesis, has antiagregantny activity.
Indications to use:
• Treatment of chronic prostatitis and prevention of possible complications after prostate gland operations.
• Pathogenetic efficiency of use of course treatment САМПРОСТ® in the rehabilitation period after operational treatment of a prostate is proved. Worldwide several million biopsies of a prostate at which, according to the research GPIU, growth of frequency and weight of possible complications is noted are annually carried out.
• Efficiency of the drug SAMPROST® at patients with a benign hyperplasia of a prostate at early stages of a disease when dysfunction is caused by disregulyatsionny processes is proved.
Route of administration and doses:
The drug is administered intramusculary on 5-10 mg within 5 - 10 days once a day. Before introduction drug dissolve in 1 ml 0,25-0,5% of solution of Procainum, solution of sodium of chloride of 0,9% or water for injections. If necessary conduct a repeated course (in 1 - 6 months).
Features of use:
Any negative influence on ability to manage vehicles and mechanisms is noted.
Side effects:
Allergic reactions are possible.
Contraindications:
Hypersensitivity to drug.
Storage conditions:
In the place protected from light at a temperature not above 20 °C. To store in the place, unavailable to children.
Issue conditions:
According to the recipe
Packaging:
10 bottles in a pack from a cardboard with the application instruction.
When packaging with solvent - 5 bottles with drug and 5 ampoules on 2 ml with solution of sodium of chloride of isotonic 0,9% in a pack from a cardboard with a knife ampoule or the scarificator and the application instruction.